MindImmune
MindImmune

MindImmune

DR24Ahrefs DR: 24/100. Below median. Measured by Ahrefs. Median 44.Agent33Agent Readiness: 33/100. Below median. Measured by StartupHub.ai. Median 41.Speed64Site Speed: 64/100. Above median. Measured by Google PageSpeed. Median 62.

Developing AI-powered diagnostics for neurodegenerative diseases.

Website
2021ActiveParis, France

About

MindImmune is a startup focused on leveraging artificial intelligence to develop novel diagnostic tools for neurodegenerative diseases. Their approach aims to enable earlier and more accurate detection, potentially leading to improved patient outcomes and treatment strategies. The company emphasizes the use of advanced AI and machine learning techniques to analyze complex biological data.

Key facts

At-a-glance profile data

Website
mindimmune.com
Headquarters
Paris, France
Founded
2021
Total funding
$35M (Strategic Investment)
Business model
B2B

Funding rounds

Funding rounds raised by MindImmune
DateRoundAmountLead investors
10 Mar 2026Strategic Investment$5MAlzheimer’s Drug Discovery Foundation
25 Nov 2025Series A$30MDolby Family Ventures

Tech stack

Detected on mindimmune.com, last scanned 9 Sept 2026. Run your own scan

CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Google Workspace
Add first review

Frequently asked

How much funding has MindImmune raised?

MindImmune has raised a total of $35M in funding. The most recent round on record is Strategic Investment.